Industry Insights
Eliciting the Hormetic Effect: The Importance of Plant Alkaloids for Treatment of Inflammation
Industry InsightToday, plant alkaloids are attracting notice as novel therapies for conditions involving inflammation, such as metabolic syndrome, autoimmune disease and even for aging, which are often characterized by chronic, low-grade over-activation of the immune system. This piece takes a closer look at the need for novel treatments and the best uses for plant alkaloids.
Read More
PCR: The "Workhorse" Technology
Industry InsightTechnology Networks spoke with Dr Jan Hellemans, CTO and co-founder of CRO Biogazelle, as well as co-author of the MIQE guidelines, to learn why PCR-based technologies are the "workhorse" technologies for the company.
Read More
A "One-and-Done" Treatment To Protect Against Heart Disease?
Industry InsightVerve Therapeutics is utilizing two of the biggest scientific breakthroughs of the twenty-first century – DNA sequencing and genome editing – to design a one-time treatment for lowering cholesterol.
Read More
The Impact of Emerging SARS-CoV-2 Variants on Diagnostic Testing
Industry InsightThe emergence of SARS-CoV-2 variants has led to concerns over the potential impacts there could be on the effectiveness of diagnostics and other countermeasures. Here, we look at the effects the B.1.1.7 variant may have on diagnostic tests.
Read More
Leveraging AI To Identify and Target Novel Cell–Cell Interactions
Industry InsightTechnology Networks recently had the pleasure of speaking with Sam Cooper, CEO and co-founder of Phenomic AI. Cooper discusses how the company is leveraging advanced machine learning techniques to interrogate cell–cell interactions responsible for driving many disease mechanisms.
Read More
A New Year in Proteomics
Industry Insight2020 was an important year for proteomics. The COVID-19 global pandemic cast a spotlight on the field's clinical utility in the fight against a public health crisis, from which there are many lessons to be drawn that will undoubtedly influence the landscape of the field for years to come. Technology Networks spoke with Rohan Thakur, executive vice president of Life Sciences Mass Spectrometry at Bruker Daltonics, to discuss the current state-of-play in proteomics.
Read More
Exploring the Relationship Between the Microbiome, Precision Medicine and Cancer
Industry InsightThe trillions of microbes contained in the human body are a key element of a personalized approach to treatment; the microbiome influences endocrinology, physiology, and even neurology, and has a crucial role in disease progression. An area in which interest is growing particularly quickly is oncology. To further investigate the link between the microbiome and cancer, we take a closer look at the current landscape of melanoma research.
Read More
2021 Predictions for Regenerative Medicine as the Pandemic Continues
Industry InsightIn 2021, we can expect the pandemic’s lingering impacts to continue to reverberate throughout regenerative medicine. With that in mind, here is a snapshot of initial expectations for the year.
Read More
New Clinical Trial Explores Safety of DMT for Substance Use Disorders
Industry InsightSubstance use disorders have a debilitating impact on the wellbeing of individuals and their families. Like many other mental health disorders, these conditions have proved stubbornly resistant to treatment. New clinical trials are exploring the safety of the psychedelic DMT for the treatment of these disorders.
Read More
Epigenetics Optimized Cell Culture Conditions To Drive and Maintain Cell Identity
Industry InsightTechnology Networks spoke with Pierre-Louis Joffrin, corporate development officer at Mogrify, to learn more about the EpiMOGRIFY platform, the advantages of using a data-driven method to maintain cell identity and support cell conversion, and the implications this could have for the development of cell therapies.
Read More
